In this study, the C3F biomarker could significantly discriminate between patients with NSCLC and healthy individuals with an area under the receiver operating characteristic curve (AUROC) of 0.78 (p < 0.0001) (Figure 2b), indicating a diagnostic potential for C3F as a biomarker. Here, LPCAT3 is linked to non-small cell lung carcinoma.